An elevated bax/bcl-2 ratio corresponds with the onset of prostate epithelial cell apoptosis

Cell Death and Differentiation

Volumn 6, Issue 1, 1999, Pages 48-54

  Perlman, Harris ^a,b,c   Zhang, Xuejun ^a   Chen, Min Wei ^a   Walsh, Kenneth ^b,c   Buttyan, Ralph ^a  

^a Coll Phys Surgs of Columbia Univ ^*  (United States)

^b TUFTS UNIVERSITY   (United States)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Bax; Bcl 2; Castration; Prostate

Indexed keywords

ANTIBODY; MESSENGER RNA; PROTEIN BAX; PROTEIN BCL 2; RIBONUCLEASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CASTRATION; CONTROLLED STUDY; GENE EXPRESSION; IMMUNOBLOTTING; IN SITU HYBRIDIZATION; MALE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROSTATE EPITHELIUM; PROTEIN EXPRESSION; RAT; RIBONUCLEASE PROTECTION ASSAY; RNA TRANSCRIPTION;

ANIMALIA;

EID: 0032892149     PISSN: 13509047     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cdd.4400453     Document Type: Article

References (22)

1. Craig RW (1995) The bcl-2 gene family. Semin. Cancer Biol. 6: 35-43
2. Hockenbery DG, Nunez G, Milliman CL, Schreiber RD and Korsmeyer SJ (1990) Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature (London) 348: 334-336
3. Yang E and Korsmeyer SJ (1996) Molecular thanatopsis: a discourse on the BCL2 family and cell death. Blood 88: 386-401
4. Oltvai ZN, Milliman CL and Korsmeyer SJ (1993) Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74: 609-619
5. Kerr JF and Searle J (1973) Deletion of cells by apoptosis during castration-induced involution of the rat prostate. Virchows Arch. Zellpathol. 13: 87-92
6. Kyprianou N and Isaacs JT (1988) Activation of programmed cell death in the rat ventral prostate after castration. Endocrin. 122: 552-562
7. Colombel MC and Buttyan R (1995) Hormonal control of apoptosis: the rat prostate gland as a model system. Methods Cell Biol. 46: 27-34
8. English HF, Drago JR and Santen RJ (1975) Cellular response to androgen depletion and repletion in the rat ventral prostate: autoradiography and morphometric analysis. The Prostate 7: 41-51
9. Sandford NL, Searle JW and Kerr JF (1984) Successive waves of apoptosis in the rat prostate after repeated withdrawal of testosterone stimulation. Pathology 16: 406-410
10. Furuya Y, Lin XS, Walsh JC, Nelson WG and Isaacs JT (1995) Androgen ablation-induced programmed death of prostatic glandular cells does not involve recruitment into a defective cell cycle or p53 induction. Endocrin. 136: 1898-1906
11. Buttyan R, Zakeri Z, Lockshin R and Wolgemuth D (1988) Cascade-induction of c-fos, c-myc, and heat shock 70K transcripts during regression of the rat ventral prostate gland. Mol. Endocrin. 2: 650-657
12. Buttyan R, Olsson CA, Pintar J, Chang C, Bandyk M, Ng P-Y and Sawczuk IS (1989) Induction of the TRPM-2 gene in cells undergoing programmed death. Mol. Cell. Biol. 9: 3473-3481
13. Zhang X, Colombel M, Raffo A and Buttyan R (1994) Enhanced expression of p53 mRNA and protein in the regressing rat ventral prostate g and. Biochem. Biophys. Res. Commun. 198: 1189-1194
14. McDonnell TJ, Troncoso P, Brisbay SM, Logothetis C, Chung LWK, Hsieh JT, Tu SM and Campbell ML (1992) Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer. Cancer Res. 52: 6940-6944
15. Berchem GJ, Bosseler M, Sugars LY, Voeller HJ, Zeitlin S and Gelman EP (1995) Androgens induce resistance to bcl-2-mediated apoptosisi in LNCaP prostate cancer cells. Cancer Res. 55: 735-738
16. Korsmeyer SJ, Shutter JR, Veis DJ, Merry DE and Oltvai Z (1993) Bcl-2/Bax: a rheostat that regulates an antioxidant pathway and cell death. Semin. Cancer Biol. 4: 327-332
17. Yin XM, Oltvai ZN and Korsmeyer SJ (1994) BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax. Nature 369: 321-323
18. Raffo AJ, Perlman H, Chen M-W, Day ML, Streitman JS and Buttyan R (1995) Overexpression of bcl-2 protects prostate cancer cells from apoptosis in vitro and confers resistance to androgen depletion in vivo. Cancer Res. 55 (19): 4438-4445
19. Colombel M, Symmans F, Gil S, O'Toole KM, Chopin D, Benson MC, Olsson CA, Korsmeyer S and Buttyan R (1993) Detection of the apoptosis-suppressing oncoprotein bcl-2 in hormone-refractory human prostate cancers. Am. J. Pathol. 143: 390-400
20. Krajewska M, Krajewski S, Epstein JI, Shabaik A, Sauvageot J, Song S, Kitada S and Reed JC (1996) Immunohistochemical analysis of bcl-2, bax, bcl-X, and mcl-1 expression in prostate cancers. Am. J. Pathol. 148: 1567-1576
21. Apakama I, Robinson MC, Walter NM, Charlton RG, Royds JA, Fuller CE, Neal DE and Hamdy FC (1996) bcl-2 overexpression combined with p53 protein accumulation correlates with hormone-refractory prostate cancer. Br. J. Cancer 74: 1258-1262
22. Tsujimoto Y and Croce CM (1986) Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma. PNAS (USA) 83: 5214-5218